In addition, an anti-B7-H3 antibody-cytotoxic drug conjugate (30) and chimeric antigen receptor (CAR)-transfected T cells targeting B7-H3 (31) showed anti-tumor activity in different experimental animal tumor models without evident toxicity. Here, CD276 is linked to neoplasm.